Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection
- 1 August 1993
- journal article
- case report
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 8 (4) , 353-357
- https://doi.org/10.1111/j.1440-1746.1993.tb01527.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitisGastroenterology, 1992
- Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implicationsJournal of Hepatology, 1992
- Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe HepatitisNew England Journal of Medicine, 1991
- Inhibition of Duck Hepatitis B Virus Replication in vivo by the Nucleoside Analogue Ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] Guanine)Antiviral Chemistry and Chemotherapy, 1991
- Liver transplantation for patients with hepatitis B: What have we learned from our results?Hepatology, 1991
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisHepatology, 1991
- The hepatitis B virus and the host responseJournal of Hepatology, 1990
- INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDSThe Lancet, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.Proceedings of the National Academy of Sciences, 1987